Tag: FDA

Do Antidepressants Increase Suicidality? Does The Black Box Warning Help or Hurt People?

Because of the black box warnings (also known as boxed warnings) on antidepressants, many people think that antidepressants cause suicidal thinking, suicidal behavior, and suicide. The black box warning on antidepressants is, after all, the strongest warning the Food and Drug Administration (FDA) can place on a medication. However, the black box warning on antidepressants was authored almost 20 years ago, and we have learned a lot and have synthesized a lot of data since then. Does this more recent data indicate that antidepressants increase suicidality or cause suicides, and what can we learn from this new information? Should we be scared of the risk of suicidality with antidepressants? (TL;DR here.)

Read More

New Drug Approved for Bipolar Depression – Lurasidone

I’m always going on and on about how there are only two medications approved to treat bipolar depression (quetiapine and a fluoxetine/olanzapine combination) and about how we need new, novel ways of treating depression in bipolar disorder.

Well, this might not be novel, but it is new.

Lurasidone (Latuda) has now been approved both as monotherapy and as adjunct therapy (with lithium or valproate) in the treatment of bipolar depression by the Food and Drug Administration (FDA). Lurasidone was tested and approved for people with bipolar I.

Read More
Get Natasha Tracy's Book

Subscribe to the Burble via Email

Additional Writings

Check out my Amazon Author Page.

I write a three-time Web Health Award winning column for HealthyPlace called Breaking Bipolar.

Also, find my writings on The Huffington Post and my work for BPHope (BP Magazine).

Archives

Subscribe for a FREE EBook!

Subscribe for a FREE EBook!

Subscribe to my monthly newsletter to get the latest from Bipolar Burble, Breaking Bipolar, my vlogs at bpHope, my masterclasses, and other useful tidbits -- plus get a FREE eBook on coping skills.

Thank you for subscribing. Look for an email to complete your subscription.